Formulation and Evaluation of Bioadhesive Buccal Drug Delivery of Tizanidine Hydrochloride Tablets

Overview

Journal AAPS PharmSciTech

Publisher Springer

Specialty Pharmacology

Date 2009 May 9

PMID 19424804

Citations 10

Authors

Gazzi Shanker

Chegonda K Kumar

Chandra Sekhara Rao Gonugunta

B Vijaya Kumar

Prabhakar Reddy Veerareddy

Affiliations

Soon will be listed here.

Abstract

The study aim was concerned with formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets, which is extensively metabolized by liver. The tablets were prepared by direct compression using bioadhesive polymers such as hydroxylpropyl methylcellulose K4M, sodium carboxymethyl cellulose alone, and a combination of these two polymers. In order to improve the permeation of drug, different permeation enhancers like beta-cyclodextrin (beta-CD), hydroxylpropyl beta-cyclodextrin (HP-beta-CD), and sodium deoxycholate (SDC) were added to the formulations. The beta-CD and HP-beta-CD were taken in 1:1 molar ratio to drug in formulations. Bioadhesion strength, ex vivo residence time, swelling, and in vitro dissolution studies and ex vivo permeation studies were performed. In vitro release of optimized bioadhesive buccal tablet was found to be non-Fickian. SDC was taken in 1%, 2%, and 3% w/w of the total tablet weight. Stability studies in natural saliva indicated that optimized formulation has good stability in human saliva. In vivo mucoadhesive behavior of optimized formulation was performed in five healthy male human volunteers and subjective parameters were evaluated.

Citing Articles

Nanonization and Deformable Behavior of Fattigated Peptide Drug in Mucoadhesive Buccal Films.

Kim W, Ngo H, Nguyen H, Park J, Lee K, Park C Pharmaceutics. 2024; 16(4).

PMID: 38675128 PMC: 11054133. DOI: 10.3390/pharmaceutics16040468.

Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac.

Koirala S, Nepal P, Ghimire G, Basnet R, Rawat I, Dahal A Heliyon. 2021; 7(3):e06439.

PMID: 33786387 PMC: 7988282. DOI: 10.1016/j.heliyon.2021.e06439.

Improved Transmucosal Delivery of Glimepiride via Unidirectional Release Buccal Film Loaded With Vitamin E TPGS-Based Nanocarrier.

Basahih T, Alamoudi A, El-Say K, Alhakamy N, Ahmed O Dose Response. 2020; 18(3):1559325820945164.

PMID: 32782450 PMC: 7401050. DOI: 10.1177/1559325820945164.

Different Types of Gel Carriers as Metronidazole Delivery Systems to the Oral Mucosa.

Wroblewska M, Szymanska E, Szekalska M, Winnicka K Polymers (Basel). 2020; 12(3).

PMID: 32204334 PMC: 7182799. DOI: 10.3390/polym12030680.

Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation.

Celik B Drug Des Devel Ther. 2017; 11:3355-3365.

PMID: 29225461 PMC: 5708193. DOI: 10.2147/DDDT.S150774.

References

Tanaka M, Yanagibashi N, Fukuda H, Nagai T . Absorption of salicylic acid through the oral mucous membrane of hamster cheek pouch. Chem Pharm Bull (Tokyo). 1980; 28(4):1056-61. DOI: 10.1248/cpb.28.1056. View

. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group. Neurology. 1994; 44(11 Suppl 9):S70-8. View

Choi H, Kim C . Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J Control Release. 2000; 68(3):397-404. DOI: 10.1016/s0168-3659(00)00276-5. View

Lee V, Yamamoto A, Kompella U . Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit Rev Ther Drug Carrier Syst. 1991; 8(2):91-192. View

Jug M, Becirevic-Lacan M . Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci. 2004; 21(2-3):251-60. DOI: 10.1016/j.ejps.2003.10.029. View

Ritthidej G, Phaechamud T, Koizumi T . Moist heat treatment on physicochemical change of chitosan salt films. Int J Pharm. 2002; 232(1-2):11-22. DOI: 10.1016/s0378-5173(01)00894-8. View

Peppas N . Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985; 60(4):110-1. View

Bottenberg P, Cleymaet R, De Muynck C, Remon J, Coomans D, Michotte Y . Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol. 1991; 43(7):457-64. DOI: 10.1111/j.2042-7158.1991.tb03514.x. View

Challa R, Ahuja A, Ali J, Khar R . Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 2005; 6(2):E329-57. PMC: 2750546. DOI: 10.1208/pt060243. View

10.

Perioli L, Ambrogi V, Angelici F, Ricci M, Giovagnoli S, Capuccella M . Development of mucoadhesive patches for buccal administration of ibuprofen. J Control Release. 2004; 99(1):73-82. DOI: 10.1016/j.jconrel.2004.06.005. View

11.

Park H, Robinson J . Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels. Pharm Res. 1987; 4(6):457-64. DOI: 10.1023/a:1016467219657. View

12.

Remunan-Lopez C, Portero A, Alonso M . Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release. 1998; 55(2-3):143-52. DOI: 10.1016/s0168-3659(98)00044-3. View

13.

Wagstaff A, Bryson H . Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs. 1997; 53(3):435-52. DOI: 10.2165/00003495-199753030-00007. View

14.

Nance P, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A . Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group. Neurology. 1994; 44(11 Suppl 9):S44-51; discussion S51-2. View

15.

Costa P, Sousa Lobo J . Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001; 13(2):123-33. DOI: 10.1016/s0928-0987(01)00095-1. View

16.

Harris D, Robinson J . Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci. 1992; 81(1):1-10. DOI: 10.1002/jps.2600810102. View

17.

Pitha J, Harman S, Michel M . Hydrophilic cyclodextrin derivatives enable effective oral administration of steroidal hormones. J Pharm Sci. 1986; 75(2):165-7. DOI: 10.1002/jps.2600750213. View

18.

Shojaei A . Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci. 2000; 1(1):15-30. View

19.

Metia P, Bandyopadhyay A . In vitro evaluation of novel mucoadhesive buccal tablet of oxytocin prepared with Diospyros peregrina fruit mucilages. Yakugaku Zasshi. 2008; 128(4):603-9. DOI: 10.1248/yakushi.128.603. View

20.

Desai K, Kumar T . Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech. 2005; 5(3):e35. PMC: 2750259. DOI: 10.1208/pt050335. View